Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a gentle brain ZAP boost speech recovery after stroke?

NCT ID NCT06048159

Recruiting now Disease control Sponsor: Medical College of Wisconsin Source: ClinicalTrials.gov ↗

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This trial investigates whether a non-invasive brain stimulation technique called tACS, applied during speech therapy, can help people recover language abilities after a stroke. The study includes 120 adults who have had a left-hemisphere stroke and experience aphasia (difficulty with language). Participants receive either real or sham tACS while doing speech exercises, and researchers measure changes in memory for sounds and everyday communication.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
transcranial alternating current stimulation (tACS)
What this could lead to
If it works, this could point toward a new way to boost speech therapy and improve language recovery after a stroke.
What could go wrong
This is an early-stage study with a moderate number of participants. The effects may be small or not translate to real-world communication improvements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APHASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aphasia stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

APHASIA STROKE

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Medical College of Wisconsin

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.